)
Edge17 Apr 2026
The New York Times Company: Adapting to the Times
How The New York Times Company built on a century-long legacy of trusted journalism to navigate disruption and reshape its business model.
Telix Pharmaceuticals
Telix Pharmaceuticals (TLX) investor relations material
Telix Pharmaceuticals Q1 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 TU earnings summary6 Apr, 2026
Executive summary
Q1 2026 group revenue reached US$230 million, an 11% increase quarter-over-quarter and 24% year-over-year, driven by strong growth in Precision Medicine and TMS segments.
Precision Medicine revenue rose 16% sequentially, with robust uptake of Illuccix and Gozellix, and U.S. dose volumes up 5% quarter-over-quarter.
Therapeutics pipeline advanced with key clinical milestones, including positive safety results in the ProstACT Phase 3 trial and regulatory progress for TLX101-Px and TLX591-Px.
Financial highlights
Group revenue for Q1 2026 was US$230 million, up 11% from Q4 2025 and 24% from Q1 2025.
Precision Medicine revenue was US$186 million, up 16% sequentially and 23% year-over-year.
TMS third-party revenue was US$44 million, up 29% year-over-year.
Outlook and guidance
FY 2026 revenue guidance reaffirmed at US$950 million to US$970 million, reflecting continued commercial momentum and full-year RLS contribution.
R&D expenditure guidance for FY 2026 remains at US$200 million to US$240 million, subject to commercial milestones.
Zircaix BLA scale-up comparability deliverables
FDA engagement for TLX591-Tx Part 2 US entry
TLX597-Tx differentiation from current therapies
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Telix Pharmaceuticals
- 56% revenue growth to $804M, robust pipeline, and FY 2026 guidance of $950M–$970M.TLX
H2 202511 Apr 2026 - 2026 revenue guidance raised to $950–$970 million, with robust pipeline and market expansion.TLXStatus update17 Mar 2026
- TLX591 plus standard care showed strong safety, tolerability, and dosimetry, enabling global expansion.TLXStudy update10 Mar 2026
- PSMA PET/CT advances and Illuccix deliver high diagnostic accuracy and drive major treatment changes.TLXStatus update5 Mar 2026
- Late-stage therapeutics, new launches, and TLX591-Tx phase 3 trials drive 2026 growth outlook.TLXTD Cowen 46th Annual Health Care Conference2 Mar 2026
- Advancing global radiopharmaceutical leadership with major clinical and commercial milestones ahead.TLXOppenheimer 36th Annual Healthcare Life Sciences Conference26 Feb 2026
- Strong growth, global expansion, and leadership transition, with all resolutions passed.TLXAGM 20253 Feb 2026
- A sterility issue delays TLX250-CDx approval, but remediation is clear and 2024 guidance is unchanged.TLXInvestor Update2 Feb 2026
- Revenue up 65% to $364M, net profit $29.7M, and $650M raised for expansion and R&D.TLXH1 202423 Jan 2026
Next Telix Pharmaceuticals earnings date
H1 202618 Aug, 2026
Telix Pharmaceuticals
Next Telix Pharmaceuticals earnings date
H1 202618 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage